NCT00951535 2023-04-06
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Cancer Trials Ireland
Phase 2 Unknown
Cancer Trials Ireland
University Hospital, Geneva
ChineseAMS
National Cancer Institute (NCI)